Home Newsfeeds Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals Q3 EPS $(0.07) Down From $(0.02) YoY

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

byBenzinga Newsdesk

November 8, 2022

1 minute read

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.07) per share. This is a 250 percent decrease over losses of $(0.02) per share from the same period last year.

Koppers Holdings Updated 2024 Outlook: Expects Sales Of ~$2.25B Vs. $2.244B Consensus And Adjusted EBITDA Of $265M-$280M (Prior ~$275M). Sees Adjusted EPS Of $4.10-$4.60 (Prior $4.60-$4.80) Vs. $4.69 Consensus

By Benzinga Newsdesk

May 3, 8:16 AM

2024 Outlook Koppers continues to expand and optimize its business and make further progress on the company's strategic pillars toward its long-term financial goals. After considering global economic

KOP

Enterprise Finl Servs Q2 EPS $1.19 Beats $1.12 Estimate, Sales $123.90M Beat $122.26M Estimate

By Michael Horton

July 25, 4:06 PM

Enterprise Finl Servs (NASDAQ:EFSC) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.12 by 6.25 percent. This is a 3.25 percent decrease over earnings of $1.23 per share from

EFSC